Elevated cyclic AMP suppresses ConA-induced MT1-MMP expression in MDA-MB-231 human breast cancer cells (original) (raw)

References

  1. Woessner JF, Jr, 1991, Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J, 5, 2145-54.
    PubMed CAS Google Scholar
  2. Birkedal-Hansen H, Moore WG, Bodden MK, et al. 1993, Matrix metalloproteinases: a review. Crit Rev Oral Biol Med, 4, 197-250.
    PubMed CAS Google Scholar
  3. Stetler-Stevenson WG, Liotta LA and Kleiner DE, 1993, Extracellular matrix 6: role of matrix metalloproteinases in tumor invasion and metastasis. FASEB J, 7, 1434-41.
    PubMed CAS Google Scholar
  4. Heppner KJ, Matrisian LM, Jensen RA and Rodgers WH, 1996, Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response. Am J Pathol, 149, 273-82.
    PubMed CAS Google Scholar
  5. Polette M and Birembaut P, 1996, Matrix metalloproteinases in breast cancer. The Breast Journal, 2, 209-20.
    Google Scholar
  6. Davies B, Miles DW, Happerfield LC, et al. 1993, Activity of type IV collagenases in benign and malignant breast disease. Br J Cancer, 67, 1126-31.
    PubMed CAS Google Scholar
  7. Lee K, Rha S, Kim S, et al. 1996, Sequential activation and production of matrix metalloproteinase-2 during breast cancer progression. Clin Exp Metastasis, 14, 512-19.
    Article PubMed CAS Google Scholar
  8. Sato H and Seiki M, 1996, Membrane-type matrix metalloproteinases (MT-MMPs) in tumor metastasis. J Biochem (Tokyo), 119, 209-15.
    CAS Google Scholar
  9. Okada A, Bellocq JP, Rouyer N, et al. 1995, Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas. Proc Natl Acad Sci USA, 92, 2730-4.
    Article PubMed CAS Google Scholar
  10. Polette M, Nawrocki B, Gilles C, et al. 1996, MT-MMP expression and localisation in human lung and breast cancers. Virchows Arch Int J Pathol, 428, 29-35.
    CAS Google Scholar
  11. Gilles C, Polette M, Birembaut P and Thompson EW, 1997, Collagen type I-induced MT1-MMP expression and MMP-2 activation: implication in the metastatic progression of breast carcinoma. Lab Invest, 76, 651-60.
    PubMed CAS Google Scholar
  12. Maniatis T, Fritsch EF and Sambrook J, 1982, _Molecular Cloning: a laboratory manual._Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
    Google Scholar
  13. Ueno H, Nakamura H, Inoue M, et al. 1997, Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast cancers. Cancer Res, 57, 2055-60.
    PubMed CAS Google Scholar
  14. Yu M, Sato H, Seiki M and Thompson EW, 1995, Complex regulation of membrane-matrix metalloproteinase expression and matrix metalloproteinase-2 activation by concanavalin A in MDA-MB-231 human breast cancer cells. Cancer Res, 55, 3272-7.
    PubMed CAS Google Scholar
  15. Pulyaeva H, Washington D, Bueno J, et al. 1997, MT1-MMP correlates with MMP-2 activation potential seen after epithelial to mesenchymal transition in human breast carcinoma cells. Clin Exp Metastasis, 15, 111-20.
    Article PubMed CAS Google Scholar
  16. Maiti SN, Yu M, Bueno J, et al. 1994, Differential regulation of matrix metalloproteinase-2 activation in human breast cancer cell lines. Ann NY Acad Sci, 732, 456-8.
    PubMed CAS Google Scholar
  17. Sato H, Takino T, Okada Y, et al. 1994, A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature, 370, 61-5.
    Article PubMed CAS Google Scholar
  18. Brooks PC, Strömblad S, Sanders LC, et al. 1996, Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin avb3. Cell, 85, 683-93.
    Article PubMed CAS Google Scholar
  19. Ailenberg M and Silverman M, 1996, Cellular activation of mesangial gelatinase A by cytochalasin D is accompanied by enhanced mRNA expression of both gelatinase A and its membrane-associated gelatinase A activator (MT-MMP). Biochem J, 313, 879-84.
    PubMed CAS Google Scholar
  20. Sato H, Takino T, Kinoshita T, et al. 1996, Cell surface binding and activation of gelatinase A induced by expression of membrane-type-1-matrix metalloproteinase (MT1-MMP). FEBS Lett, 385, 238-40.
    Article PubMed CAS Google Scholar
  21. Lohi J, Lehti K, Westermarck J, Kahari VM and Keski-Oja J, 1996, Regulation of membrane-type matrix metalloproteinase-1 expression by growth factors and phorbol 12-myristate 13-acetate. Eur J Biochem, 239, 239-47.
    Article PubMed CAS Google Scholar
  22. Yu M, Sato H, Seiki M, Spiegel S and Thompson EW, 1997, Calcium influx inhibits MT1-MMP processing and blocks MMP-2 activation. FEBS Lett, 412, 568-72.
    Article PubMed CAS Google Scholar
  23. Keski-Oja J, Lehti J and Lohi J, 1977, Proteolytic activation of membrane-type matrix metalloproteinase-1. Proc Am Assn Cancer Res, 38, 166 (abstract).
    Google Scholar
  24. Strongin AY, Collier I, Bannikov G, Marmer BL, Grant GA and Goldberg GI, 1995, Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. J Biol Chem, 270, 5331-8.
    Article PubMed CAS Google Scholar
  25. Horgan AF, O'Riordain DS, Chin DH, Mannick JA and Rodrick ML, 1994, The role of cyclic adenosine monophosphate in the suppression of cellular immunity after thermal injury. Arch Surg, 129, 1284-9.
    PubMed CAS Google Scholar
  26. Uotila P, 1996, The role of cyclic AMP and oxygen intermediates in the inhibition of cellular immunity in cancer. Cancer Immunol Immunother, 43, 1-9.
    PubMed CAS Google Scholar
  27. Corcoran ML, Stetler-Stevenson WG, De Witt DL and Wahl LM, 1994, Effect of cholera toxin and pertussis toxin on prostaglandin H synthase-2, prostaglandin E2, and matrix metalloproteinase production by human monocytes. Arch Biochem Biophys, 310, 481-8.
    Article PubMed CAS Google Scholar
  28. Borger P, Kauffman HF, Postma DS and Vellenga E, 1996, Interleukin-4 gene expression in activated human T lymphocytes is regulated by the cyclic adenosine monophosphate-dependent signaling pathway. Blood, 87, 691-8.
    PubMed CAS Google Scholar
  29. Borger P, Kauffman HF, Vijgen JL, Postma DS and Vellenga E, 1996, Activation of the cAMP-dependent signaling pathway downregulates the expression of interleukin-3 and granulocyte-macrophage colonystimulating factor in activated human T lymphocytes. Exp Hematol, 24, 108-15.
    PubMed CAS Google Scholar
  30. Iyengar R, 1996, Gating by cyclic AMP: expanded role for an old signaling pathway. Science, 271, 461-3.
    PubMed CAS Google Scholar

Download references